Cyanotech

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024

Retrieved on: 
Thursday, February 8, 2024
Operating cost, Dietary supplement, Commercial, Microalgae, Corporation, Marketing, Interest, Cyanotech, Security (finance)

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023.
  • Operating loss for the third quarter of fiscal 2024 was $848,000 compared to operating loss of $404,000 in the same period of the prior year.
  • Cyanotech reported net sales of $17,101,000 for the first nine months of fiscal 2024 compared to $17,786,000 for the same period in fiscal 2023, a decrease of 3.9%.
  • The Company will respond only to relevant questions relating to the Company’s third quarter fiscal 2024 financial performance and will not be accepting any questions or comments during the broadcast.

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024

Retrieved on: 
Wednesday, November 8, 2023
Alternative Medicine, Retail, Health, Fitness & Nutrition, Specialty, Vitamins, Supplements, Microalgae, EST, Interest, Operating cost, Cyanotech, Corporation, Security (finance)

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2024, ended September 30, 2023.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2024, ended September 30, 2023.
  • Commenting on the second quarter fiscal year 2024 results, Cyanotech’s President and Chief Executive Officer, Matthew K. Custer, said:
    “The sales in the quarter are trending in the right direction with a 23.1% increase versus prior year.
  • Operating loss for the second quarter of fiscal 2024 was $632,000 compared to operating loss of $837,000 in the same period of the prior year.
  • Cyanotech reported net sales of $11,519,000 for the first six months of fiscal 2024 compared to $11,895,000 for the same period in fiscal 2023, a decrease of 3.2%.

Charlotte's Web Appoints Angela McElwee, Former CEO of Gaia Herbs, to Board of Directors

Retrieved on: 
Thursday, October 12, 2023
Woman, Knowledge, TSX, Audit committee, Compensated emancipation, Business, CWEB, Nature, Charlotte's Web, Growth, Marketing, Appian Way Productions, CBD, Miami University, CPG, Cyanotech, Children & Nature Network, Management, Cheese, Biology

Angela McElwee is a seasoned executive with expertise in building businesses and brands within the natural products industry.

Key Points: 
  • Angela McElwee is a seasoned executive with expertise in building businesses and brands within the natural products industry.
  • From April 2008 to January 2021, she was an executive at Gaia Herbs, Inc. ("Gaia"), where she also served on the Board of Directors from 2013-2021.
  • Gaia Herbs is an award-winning natural herbal products brand offering more than 200 quality herbal products in North America.
  • She currently serves on the Board of Directors of Cyanotech Inc. a Nasdaq-listed company, where she serves on the Audit Committee.

American Public University System's Supernova Search Group Receives NASA Grant to Conduct Research on Plants in Outer Space

Retrieved on: 
Tuesday, September 12, 2023
University of Hawaiʻi, AMU, Partnership, Food, University, American Public University System, Life, UND, APUS, Microalgae, Temperature, Established Programs Financing, Inflatable, Plant, Student, Soil, NASA, West Hawai'i Explorations Academy, Goddard Institute for Space Studies, Commercial, Health, Agriculture, Nursing, Spirulina, Cyanotech, Mars, Moon, Research

CHARLES TOWN, W.Va., Sept. 12, 2023 /PRNewswire/ -- American Public University System (APUS) today announced that the Spirulina Algae Group, part of the University's Supernova Search Group, has received a NASA research grant to study the use of spirulina, a blue-green algae, for growing plants in space environments. The research focuses on the use of Hawaiian Spirulina Pacifica®1, scientifically known as Arthrospira platensis, to help support plant health, nutritional value, and production rates for many plants in similar conditions to Mars and the Moon.  

Key Points: 
  • The research seeks to identify sustainable solutions to help support astronauts on prolonged missions using algae-based systems.
  • The research, funded by NASA's Established Program to Stimulate Competitive Research (EPSCoR) , will help in NASA's development of an outer space settlement capable of growing its own food and supporting human life.
  • The Spirulina Group includes Dr. Miller, American Public University undergraduate student Emma Follis; American Military University alums Terry Trevino and Dr. Larry Harrison (professor, University of Hawaii); Erin Stamper (Cyanotech Corporation); and Dr. Brian Murphy (West Hawaii Explorations Academy).
  • "We're very excited about what the future holds for this dynamic, faculty-led student research team," said APUS Provost Dr. Elizabeth Johnson.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024

Retrieved on: 
Friday, August 11, 2023
Vitamins, Supplements, Fitness & Nutrition, Specialty, Biotechnology, Alternative Medicine, Health, Agriculture, Retail, Natural Resources, Online Retail, Cyanotech, Chief commercial officer, Operating cost, Interest, Commercial, Corporation, EDT

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023.
  • Commenting on the first quarter fiscal year 2024 results, Cyanotech’s President and Chief Executive Officer, Matthew K. Custer, said:
    “This quarter we continue to see the impact of consumers shifting their spend from goods to experiences and services and reallocation of spending related to the high cost of living.
  • Operating loss for the first quarter of fiscal 2024 was $1,209,000 compared to operating loss of $425,000 in the same period of the prior year.
  • The Company will respond only to relevant questions relating to the Company’s first quarter fiscal 2024 financial performance and will not be accepting any questions or comments during the broadcast.

Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment

Retrieved on: 
Tuesday, August 1, 2023
Other Retail, Pharmaceutical, Other Natural Resources, Specialty, Agriculture, Natural Resources, Fitness & Nutrition, Retail, Biotechnology, Alternative Medicine, Vitamins, Supplements, Health, Cyanotech, Chief commercial officer, Corporation, Family, Environment, Marketing, Water, Microalgae, Management

Ms. Kakuk brings an impressive background in business development, strategy, and marketing to add significant value to Cyanotech’s growing stable of products.

Key Points: 
  • Ms. Kakuk brings an impressive background in business development, strategy, and marketing to add significant value to Cyanotech’s growing stable of products.
  • Her industry experience, combined with a passionate drive for sustainable and authentic product sourcing, makes her an ideal addition to Cyanotech’s executive team.
  • Recognizing growing global interest in microalgae and its health benefits, Ms. Kakuk is excited about the company’s future.
  • It’s the essence of who Cyanotech is, and has been, since day one.”

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023

Retrieved on: 
Tuesday, June 27, 2023
Vitamins, Supplements, Other Retail, Fitness & Nutrition, Specialty, Biotechnology, Alternative Medicine, General Health, Pharmaceutical, Health, Retail, Cyanotech, Operating cost, Interest, Corporation, EDT, Spirulina, Security (finance)

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2023, ended March 31, 2023.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2023, ended March 31, 2023.
  • Cyanotech reported net sales of $5,391,000 for the fourth quarter of fiscal year 2023 compared to $8,126,000 in the fourth quarter of fiscal 2022, a decrease of 33.7%.
  • Operating loss was $1,255,000 compared to operating income of $364,000 in the fourth quarter of fiscal 2022.
  • The Company will respond only to relevant questions relating to the Company’s fourth quarter and fiscal 2023 financial performance and will not be accepting any questions or comments during the broadcast.

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023

Retrieved on: 
Thursday, February 9, 2023
Vitamins, Supplements, Fitness & Nutrition, Specialty, Other Health, Alternative Medicine, General Health, Pharmaceutical, Health, Retail, Online Retail, Cyanotech, EST, Interest, Corporation, Operating cost, Cryptocurrency, Security (finance)

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2023, ended December 31, 2022.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2023, ended December 31, 2022.
  • Operating loss for the third quarter of fiscal 2023 was $404,000 compared to operating income of $508,000 in the same period of the prior year.
  • Cyanotech reported net sales of $17,786,000 for the first nine months of fiscal 2023 compared to $27,842,000 for the same period in fiscal 2022, a decrease of 36.1%.
  • The Company will respond only to relevant questions relating to the Company’s third quarter fiscal 2023 financial performance and will not be accepting any questions or comments during the broadcast.

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023

Retrieved on: 
Wednesday, November 9, 2022
Retail, Health, Other Health, Fitness & Nutrition, Specialty, Vitamins, Supplements, Operating cost, Nasdaq, Forward-looking statement, Marketing, Health, Microalgae, U.S. Securities and Exchange Commission, Weather, Food, EST, Food and Drug Administration, File, Eye, Private Securities Litigation Reform Act, Interest, Generally recognized as safe, Forgiveness, Company, Disease, Corporation, Skin, Paycheck Protection Program, Table, Security (finance), Cyanotech, Income, Management, Dietary supplement, Spirulina

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2023, ended September 30, 2022.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2023, ended September 30, 2022.
  • Cyanotech reported net sales of $5,179,000 for the second quarter of fiscal 2023 compared to $9,419,000 for the second quarter of fiscal 2022, a decrease of 45.0%.
  • Operating loss for the second quarter of fiscal 2023 was $837,000 compared to operating income of $1,082,000 in the same period of the prior year.
  • Cyanotech reported net sales of $11,895,000 for the first six months of fiscal 2023 compared to $18,383,000 for the same period in fiscal 2022, a decrease of 35.3%.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023

Retrieved on: 
Wednesday, August 10, 2022
Alternative Medicine, Health, Fitness & Nutrition, Vitamins, Supplements, Pharmaceutical, Biotechnology, U.S. Securities and Exchange Commission, Paycheck Protection Program, Table, Forward-looking statement, Food and Drug Administration, Generally recognized as safe, Disease, Microalgae, Security (finance), Nasdaq, Income, Cyanotech, Company, Eye, Skin, Corporation, Operating cost, File, Private Securities Litigation Reform Act, EDT, Weather, Interest, Food, Health, Forgiveness, Dietary supplement

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2023, ended June 30, 2022.

Key Points: 
  • Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2023, ended June 30, 2022.
  • Commenting on the first quarter fiscal 2023 results, Cyanotechs President and Chief Executive Officer, Matthew K. Custer, said: The disappointing results in the first quarter were driven primarily by the $2.2 million decrease in sales and a higher cost per kilo of astaxanthin.
  • Cyanotech reported net sales of $6,716,000 for the first quarter of fiscal 2023 compared to $8,964,000 for the first quarter of fiscal 2022, a decrease of 25.1%.
  • Operating loss for the first quarter of fiscal 2023 was $425,000 compared to operating income of $619,000 in the same period of the prior year.